Emkay Global Financial's research report on Exide Industries
Exide’s Q3 revenue increased 7% YoY to Rs34.1bn, below our estimate of Rs36.1bn, owing to lower-than-expected sales in the replacement and overseas segments. EBITDA grew by 7% YoY to Rs4bn, lower than our estimate by 8% due to revenue miss. We reduce our FY23-25E EPS by 2-4%, mainly due to lower revenue assumptions. Despite losing out in the PLI-ACC scheme, EXID plans to set up a lithium-ion cell manufacturing facility, commissioning of which is expected after two years. Any progress on tie-ups with OEMs for battery supplies could provide clarity on Exide’s long-term growth prospects.
Outlook
We retain HOLD, with TP of Rs202/share (Rs205 earlier), based on 11x FY25E EPS and value of HDFC Life stake at Rs57/share.
For all recommendations report, click here
Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
Find the best of Al News in one place, specially curated for you every weekend.
Stay on top of the latest tech trends and biggest startup news.